ABATTIS BIOCEUTICALS: Joins an Index and Runs with the Herd https://www.abattis.com https://marijuanaindex.com/stock-profile/?qm_symbol=ATTBF
By Jermaine Farmer - April 10, 2017
ABATTIS BIOCEUTICALS COM NPV (OTCMKTS:ATTBF)
is a penny play in the Canadian MMJ space that has been red hot in recent days. As most readers are probably aware – and something we have been talking about quite a bit over the past 3 months – the Canadian government is preparing to officially begin a process of full-scale, nationwide legalization of marijuana for both medical and recreational purposes. We think that is likely helping to fuel gains in ATTBF. However, there are a couple other catalysts.
Among them is the company’s announcement that it has officially been added to The Marijuana Index, within the Biotechnology sector. According to the release, “the North American Marijuana Index tracks the leading public cannabis companies operating in the United States and Canada and gives investors up to date, centralized news on the securities deemed to be well positioned within the multi-billion dollar cannabis industry. Selected companies must meet stringent trading guidelines including having a minimum market capitalization of $30 million and daily trading volumes of above $400K.”
ABATTIS BIOCEUTICA COM NPV (OTCMKTS:ATTBF) casts itself as a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.
In essence, the company develops, licenses, and markets health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets in Canada. It is also involved in the possession of cannabis and related active ingredients, as well as the production of extracts; and bioceutical marketing services in the area of health products.
The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corp. in September 2012. Abattis Bioceuticals Corp. was incorporated 1997 and is headquartered in Langley, Canada.
According to company materials, “Abattis is a specialty agricultural technology and biotechnology company which aggregates, integrates, and invests in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. The Company is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds. The Company follows strict standard operating protocols, and adheres to the applicable laws of Canada and foreign jurisdictions.”
As discussed above, ATTBF shares are likely running in part due to the Liberal government’s upcoming announcement, coming today (according to prior announcements), about legislation that will legalize recreational marijuana use across Canada by July 1, 2018. As reported by the CBC, Trudeau’s government will follow the recommendations of a federally appointed task force, led by former liberal Justice Minister Anne McLellan, and in doing so, will look to deliver on their controversial campaign promise of introducing legislation by the Spring of 2017.
However, as we noted, there are also a few company-specific catalysts to consider. The inclusion in an index of marijuana stocks should not be overlooked. Legitimacy, as we have pointed out recently in other pieces on Oracle Dispatch, is the fundamental objective of companies in the MMJ space at this young stage of the game.
“We are delighted to have Abattis added to the The Marijuana Index and look forward to sharing our story with investors closely tracking this exciting sector,” stated Abattis CFO, Rene David. “As we approach sector legalization, we’ll start to see markets broaden their reach from the closely covered cultivation and growing players to those advancing the technology and biosciences side of the cannabis industry,” added Mr. David.
Recent action has seen 79% tacked on to share pricing for the stock in the past month. The situation may be worth watching. ATTBF has evidenced sudden upward volatility on many prior occasions. In addition, the company has witnessed a pop in interest, as transaction volume levels have recently pushed nearly 250% above the average volume levels in play in this stock over the longer term.
Earning a current market cap value of $33.1M, ATTBF has a store ($460K) of cash on the books, which stands against virtually no total current liabilities. The company is, for all practical purposes, a pre-revenue company at this point, which is important and, at first glance, unexpected. We will update the story again soon as further details emerge.